Tatva Chintan Pharma Chem has reported results for third quarter ended December 31, 2021.
The company has reported a rise of 12.26% in its net profit at Rs 22.43 crore for the quarter under review as compared to Rs 19.98 crore for the same quarter in the previous year. Total income of the company increased by 38.66% at Rs 106.67 crore for Q3FY22 as compared Rs 76.93 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a rise of 9.25% in its net profit at Rs 22.80 crore for the quarter under review as compared to Rs 20.87 crore for the same quarter in the previous year. Total income of the company increased by 35.43% at Rs 109.39 crore for Q3FY22 as compared Rs 80.77 crore for the corresponding quarter previous year.
